New shot aims to silence hepatitis b virus
NCT ID NCT03365947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called ARO-HBV in healthy volunteers and people with chronic hepatitis B. The drug uses RNA interference to try to stop the virus from multiplying. The main goal was to check safety and how the body processes the drug, not yet to prove it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ARO-HBV (an RNA interference drug given as a shot)
What this could lead to
If it works, this could lead to a new way to control hepatitis B virus levels, possibly reducing the need for lifelong daily pills.
What could go wrong
This is an early phase 1/2a trial focused on safety and dosing, not yet on effectiveness. Many drugs that look safe in early trials fail to show enough benefit in later, larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Grafton, Auckland, 1010, New Zealand
-
Research Site 2
Papatoetoe, Auckland, 2025, New Zealand
-
Research Site 3
Melbourne, Victoria, 3065, Australia
-
Research Site 4
Clayton, Victoria, 3168, Australia
-
Research Site 5
Camperdown, New South Wales, 2050, Australia
-
Research Site 6
Nedlands, Western Australia, 6009, Australia
-
Research Site 7
Hong Kong, Hong Kong